Apella Capital
WST icon

Apella Capital’s West Pharmaceutical WST Stock Holding History

Apella Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.18M Buy
16,876
+20
+0.1% +$7.06K 0.08% 166
2026
Q2 		$6M Buy
16,856
+18
+0.1% +$5.5K 0.08% 152
2026
Q1 		$4.61M Buy
16,838
+7
+0% +$1.74K 0.07% 166
2025
Q4 		$4.63M Buy
16,831
+8
+0% +$2.19K 0.09% 136
2025
Q3 		$4.49M Buy
16,823
+8
+0% +$1.94K 0.1% 128
2025
Q2 		$3.72M Buy
16,815
+15
+0.1% +$3.21K 0.1% 125
2025
Q1 		$3.42M Sell
16,800
-1
-0% -$276 0.12% 106
2024
Q4 		$5.5M Sell
16,801
-7
-0% -$2.2K 0.21% 74
2024
Q3 		$5.04M Buy
16,808
+13
+0.1% +$3.98K 0.21% 67
2024
Q2 		$5.35M Sell
16,795
-1
-0% -$353 0.24% 62
2024
Q1 		$6.59M Sell
16,796
-34
-0.2% -$12.6K 0.33% 54
2023
Q4 		$5.73M Sell
16,830
-115
-0.7% -$40.7K 0.32% 60
2023
Q3 		$6.36M Sell
16,945
-85
-0.5% -$32.9K 0.45% 47
2023
Q2 		$6.51M Buy
+17,030
New +$6.08M 0.46% 47
2022
Q4 		$4.1M Sell
17,400
-210
-1% -$49.8K 0.37% 54
2022
Q3 		$4.33M Sell
17,610
-200
-1% -$60.9K 0.5% 46
2022
Q2 		$5.38M Buy
17,810
+160
+0.9% +$52.1K 0.64% 37
2022
Q1 		$7.25M Buy
17,650
+4,000
+29% +$1.57M 1.02% 28
2021
Q4 		$6.4M Sell
13,650
-90
-0.7% -$38.7K 0.82% 32
2021
Q3 		$5.83M Sell
13,740
-135
-1% -$56.9K 0.84% 34
2021
Q2 		$4.98M Hold
13,875
– – 0.82% 32
2021
Q1 		$3.91M Hold
13,875
– – 1.23% 26
2020
Q4 		$3.93M Buy
13,875
+1,047
+8% +$294K 1.38% 23
2020
Q3 		$3.53M Hold
12,828
– – 1.42% 22
2020
Q2 		$2.91M Hold
12,828
– – 1.36% 20
2020
Q1 		$1.95M Buy
+12,828
New +$1.97M 1.14% 24

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Apella Capital's WST Position: Q3 2026 in Review

Apella Capital increased its West Pharmaceutical (WST) stake by 0.12% in Q3 2026, buying an estimated $7.06K and bringing the position to 16,876 shares worth $6.18M. The position accounts for 0.08% of the portfolio, ranked #166.

Apella Capital first reported a position in WST in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.25M in Q1 2022. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Apella Capital held 16,876 shares of West Pharmaceutical worth $6.18M as of Q3 2026.
  • Apella Capital bought 20 West Pharmaceutical shares in Q3 2026, an estimated $7.06K.
  • West Pharmaceutical made up 0.08% of Apella Capital's portfolio in Q3 2026, its #166 holding.
  • Apella Capital first reported a position in West Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Apella Capital's West Pharmaceutical position peaked at $7.25M in Q1 2022.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.